Business, energy, technology, markets and global industry news from Business News Today

Stanford University

PharmaDeviceNews Stanford University
Vero Bioscience is combining Stanford University’s proteomic organ-aging and Cell Clock technologies to develop OrganAge, a blood-based platform designed to assess biological aging across organs and cell types as the company moves toward broader consumer availability in 2027. Representative image.
Medical Devices & Diagnostics

Can one blood test reveal which cells are aging fastest? Vero brings Stanford Cell Clock into OrganAge

Vero adds Stanford Cell Clock technology to OrganAge ahead of a 2027 rollout, while clinical validation remains the key commercial test.

Read More
Adaptyx Biosciences and Attune Neurosciences are studying whether wearable molecular sensing and neuromodulation data can help identify objective biomarkers linked to chronic pain and treatment response. Representative image.
Medical Devices & Diagnostics

Can a wearable make chronic pain measurable? Adaptyx and Attune put five biomarkers to the test

Adaptyx and Attune begin a $4 million ARPA-H-backed study testing continuous biomarkers and focused ultrasound in 100 adults with chronic pain.

Read More